Can incorporating molecular testing improve the accuracy of newborn screening for congenital adrenal hyperplasia?

Kyriakie SarafoglouAmy GaviglioCarrie WolfCindy P LorentzAida LteifJennifer KylloGretchen RadloffZachary DetwilerCarla D CuthbertJames S HodgesScott D GrosseChristopher N GreeneSuzanne Cordovado

Published in: The Journal of clinical endocrinology and metabolism (2024)

Incorporation of molecular testing could improve the accuracy of CAH NBS, although some distinct challenges of molecular testing may need to be considered before implementation by NBS programs.

Keyphrases

healthcare
primary care
single molecule
public health
quality improvement